Search hospitals > Washington > Tacoma
MultiCare Tacoma General Hospital
Claim this profileTacoma, Washington 98405
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Ovarian Cancer
Conducts research for Lung Cancer
Conducts research for Adenocarcinoma
258 reported clinical trials
7 medical researchers
Summary
MultiCare Tacoma General Hospital is a medical facility located in Tacoma, Washington. This center is recognized for care of Cancer, Breast Cancer, Ovarian Cancer, Lung Cancer, Adenocarcinoma and other specialties. MultiCare Tacoma General Hospital is involved with conducting 258 clinical trials across 384 conditions. There are 7 research doctors associated with this hospital, such as Jennifer Slim, Steven Phillips, John A. Keech, and Laila Rashidi, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderHER2 negative
ER positive
Stage IV
Top PIs
Jennifer SlimMultiCare Tacoma General Hospital6 years of reported clinical research
Studies Cancer
Studies Breast Cancer
18 reported clinical trials
50 drugs studied
Steven PhillipsMary Bridge Children's Neurology4 years of reported clinical research
Studies Syndrome
Studies Migraine
5 reported clinical trials
3 drugs studied
John A. KeechMultiCare Auburn Medical Center9 years of reported clinical research
Studies Breast Cancer
Studies Ovarian Cancer
3 reported clinical trials
12 drugs studied
Laila Rashidi, MDMultiCare - Tacoma1 year of reported clinical research
Studies Colorectal Cancer
Studies Ureter Injury
2 reported clinical trials
2 drugs studied
Clinical Trials running at MultiCare Tacoma General Hospital
Breast Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Bladder Cancer
Cancer
Colorectal Cancer
Pancreatic Carcinoma
Coronavirus
Migraine
Pancreatic Cancer
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Omitting Radiation Therapy
for Breast Cancer
The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at MultiCare Tacoma General Hospital?
MultiCare Tacoma General Hospital is a medical facility located in Tacoma, Washington. This center is recognized for care of Cancer, Breast Cancer, Ovarian Cancer, Lung Cancer, Adenocarcinoma and other specialties. MultiCare Tacoma General Hospital is involved with conducting 258 clinical trials across 384 conditions. There are 7 research doctors associated with this hospital, such as Jennifer Slim, Steven Phillips, John A. Keech, and Laila Rashidi, MD.